Shattuck Labs, Inc.
Shattuck Labs is a clinical-stage biotechnology company specializing in the development of TNF receptor modulators. Their lead program, SL-325, is a potentially first-in-class monoclonal antibody antagonist of Death Receptor 3 (DR3), designed to achieve deeper blockade of the TL1A/DR3 pathway. They aim to deliver transformational medicines for oncology and autoimmune/inflammatory diseases using novel protein engineering approaches.
Registro Oficial
Análisis de Calidad IA
Desglose de Puntuación de Confianza
Enlaces Rápidos
Destacados del sitio web
🌟 Empresas similares de confianza
Protalix BioTherapeutics, Inc.
Protalix is dedicated to bringing to market recombinant therapeutic proteins with clinically improved profiles, produced with their ProCellEx® plant cell-based expression system. They focus on treating rare diseases and have already launched two enzyme replacement therapies. The company is known for its innovative ProCellEx® technology.
Immunocore Holdings plc
Immunocore Holdings plc pioneers TCR therapy, aiming to improve outcomes for patients with cancer, infectious, and autoimmune diseases. They develop transformative immunomodulating medicines using their ImmTAX technology. This technology activates the immune system to recognize and destroy diseased cells.
PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
PacBio provides advanced DNA sequencing solutions, including Revio, Vega, and Onso systems. They are known for their HiFi long-read and SBB short-read technologies, used in research across human, plant, and microbial genomics. The company is positioned as a leading provider for precise and comprehensive genetic analysis.